Seg Ventures, Llc Acquires 30,000 Shares of Mesa Laboratories, Inc. (MLAB) Stock

Share on StockTwits

Mesa Laboratories, Inc. (NASDAQ:MLAB) Director Seg Ventures, Llc bought 30,000 shares of the stock in a transaction on Friday, October 12th. The shares were bought at an average price of $21.52 per share, for a total transaction of $645,600.00. Following the purchase, the director now directly owns 120,000 shares in the company, valued at approximately $2,582,400. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Seg Ventures, Llc also recently made the following trade(s):

  • On Friday, December 21st, Seg Ventures, Llc bought 40,000 shares of Mesa Laboratories stock. The shares were bought at an average price of $24.75 per share, for a total transaction of $990,000.00.
  • On Sunday, December 30th, Seg Ventures, Llc bought 20,000 shares of Mesa Laboratories stock. The shares were bought at an average price of $23.10 per share, for a total transaction of $462,000.00.

Shares of NASDAQ:MLAB traded up $1.49 during trading on Friday, hitting $181.50. The company’s stock had a trading volume of 33,700 shares, compared to its average volume of 20,231. Mesa Laboratories, Inc. has a 12 month low of $122.35 and a 12 month high of $224.95. The company has a quick ratio of 1.55, a current ratio of 2.10 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $691.87 million, a PE ratio of 29.41 and a beta of 0.24.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings data on Tuesday, July 31st. The medical instruments supplier reported $1.06 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.79 by $0.27. Mesa Laboratories had a negative net margin of 0.25% and a positive return on equity of 15.92%. The firm had revenue of $25.14 million for the quarter. Analysts expect that Mesa Laboratories, Inc. will post 7.09 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 17th. Stockholders of record on Friday, November 30th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend is Thursday, November 29th. Mesa Laboratories’s dividend payout ratio (DPR) is presently 10.36%.

Several large investors have recently modified their holdings of the company. Sapphire Star Partners LP lifted its stake in shares of Mesa Laboratories by 8.0% in the 2nd quarter. Sapphire Star Partners LP now owns 5,351 shares of the medical instruments supplier’s stock worth $1,129,000 after purchasing an additional 397 shares during the period. Rhumbline Advisers lifted its stake in shares of Mesa Laboratories by 15.0% in the 2nd quarter. Rhumbline Advisers now owns 3,176 shares of the medical instruments supplier’s stock worth $670,000 after purchasing an additional 415 shares during the period. Yorktown Management & Research Co Inc lifted its stake in shares of Mesa Laboratories by 15.0% in the 2nd quarter. Yorktown Management & Research Co Inc now owns 3,564 shares of the medical instruments supplier’s stock worth $752,000 after purchasing an additional 464 shares during the period. Wells Fargo & Company MN lifted its stake in shares of Mesa Laboratories by 12.4% in the 1st quarter. Wells Fargo & Company MN now owns 6,631 shares of the medical instruments supplier’s stock worth $985,000 after purchasing an additional 729 shares during the period. Finally, Bank of New York Mellon Corp lifted its stake in shares of Mesa Laboratories by 5.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 18,858 shares of the medical instruments supplier’s stock worth $3,980,000 after purchasing an additional 958 shares during the period. Hedge funds and other institutional investors own 71.91% of the company’s stock.

MLAB has been the topic of several research analyst reports. TheStreet upgraded shares of Mesa Laboratories from a “c” rating to a “b” rating in a research note on Thursday, June 28th. BidaskClub cut shares of Mesa Laboratories from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 18th. Zacks Investment Research upgraded shares of Mesa Laboratories from a “hold” rating to a “buy” rating and set a $248.00 target price on the stock in a research note on Wednesday, July 11th. Finally, ValuEngine cut shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Thursday, October 4th.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.

Featured Story: What does the Dow Jones Industrial Average (DJIA) measure?

Insider Buying and Selling by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Meridian Bancorp Inc  to Issue Quarterly Dividend of $0.07 on  January 2nd
Meridian Bancorp Inc to Issue Quarterly Dividend of $0.07 on January 2nd
Devon Energy Corp  To Go Ex-Dividend on December 13th
Devon Energy Corp To Go Ex-Dividend on December 13th
Analysts Set $20.60 Target Price for Bain Capital Specialty Finance Inc
Analysts Set $20.60 Target Price for Bain Capital Specialty Finance Inc
WhiteHorse Finance Inc  Announces $0.36 Quarterly Dividend
WhiteHorse Finance Inc Announces $0.36 Quarterly Dividend
Laurion Capital Management LP Takes $738,000 Position in Sally Beauty Holdings, Inc.
Laurion Capital Management LP Takes $738,000 Position in Sally Beauty Holdings, Inc.
30,000 Shares in A10 Networks Inc  Acquired by King Luther Capital Management Corp
30,000 Shares in A10 Networks Inc Acquired by King Luther Capital Management Corp


© 2006-2018 Ticker Report